MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s0360-3016(98)00310-1

Медицинская библиотека · International journal of radiation oncology, biology, physics · 1998

Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study.

Lee D J, Trotti A, Spencer S, Rostock R, Fisher C, von Roemeling R, Harvey E, Groves E

Клиническое исследованиеКлиническое исследование II фазыСтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: To evaluate the efficacy and toxicity of tirapazamine, a hypoxic cytotoxin, combined with conventional radiotherapy (RT) for advanced head and neck carcinomas.

MATERIALS AND

METHODS

From Oct. 1994 to Nov. 1996, 40 patients with stage III or IV carcinomas of the head and neck were enrolled in a Phase II trial to receive conventional RT (70 Gy in 7 weeks) with concurrent tirapazamine (159 mg/m2 intravenously, 3 times per week for 12 doses). One patient subsequently withdrew from the protocol treatment, and was excluded from analyses. Among the 39 cases, the primary sites were located in the oropharynx (n = 28), supraglottic larynx (n = 6), or hypopharynx (n = 5). Twenty-seven patients had T3 or T4, and 27 had N2 or N3 disease.

RESULTS

Thirty-two (82%) patients received full 12 drug doses. Thirty-two patients (82%) received full 70 Gy of RT. The most frequent drug toxicities were muscle cramps (77%) and nausea/vomiting (62%), usually grade 1 or 2. Overall, 13 patients (33%) experienced grade 3 or 4 drug-related toxicities. No excessive RT-associated acute normal tissue reactions were observed. With a median follow-up of 13 months, the 1-year and 2-year local control rate was 64% and 59% respectively.

CONCLUSION

The tirapazamine regimen was well tolerated with a compliance rate of 82%. The toxicity of RT with concurrent tirapazamine was acceptable in treating advanced head and neck carcinomas. The disease control trend was encouraging. Further clinical studies are warranted.

Для цитирования: Lee D J, Trotti A, Spencer S, Rostock R, Fisher C, von Roemeling R, Harvey E, Groves E. Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study.. International journal of radiation oncology, biology, physics. 1998. DOI: 10.1016/s0360-3016(98)00310-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.